C5L2 receptor is not involved in C3a / C3a-desArg-mediated enhancement of bone marrow hematopoietic cell migration to CXCL12.
M
M
Honczarenko
B
B
Lu
A
A
Nicholson-Weller
N P
NP
Gerard
L E
LE
Silberstein
C
C
Gerard
D000818:Animals; D001854:Bone Marrow Cells; D002465:Cell Movement / Q000187:drug effects / Q000502:physiology; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000502:physiology*; D015926:Complement C3a / Q000494:pharmacology* / Q000502:physiology; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000502:physiology*; D051379:Mice; D018345:Mice, Knockout; D044087:Receptor, Anaphylatoxin C5a / Q000502:physiology*
D054377:Chemokine CXCL12; D019743:Chemokines, CXC; C515256:Cxcl12 protein, mouse; D044087:Receptor, Anaphylatoxin C5a; C044541:complement C3a, des-Arg-(77)-; D015926:Complement C3a